Related Experiment Video
Updated: Feb 7, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Prognostic Factors in Anti-Neuronal Antibody Positive Patients
Çağla Aydin1, Şenay Yıldız Çelik1, Sema İçöz1
1Department of Neurology, Istanbul University, Faculty of Medicine, İstanbul, Turkey.
Anti-neuronal antibody (ANA) type is the primary prognostic factor in patients with neurological syndromes. Antibody targeting extracellular or synaptic antigens indicates a good prognosis and treatment response, regardless of tumor presence or MRI findings.
Area of Science:
- Neurology
- Immunology
- Oncology
Background:
- Anti-neuronal antibodies (ANA) are biomarkers in paraneoplastic neurological syndromes and autoimmune encephalitis.
- Understanding prognostic factors in ANA-seropositive patients is crucial for clinical management.
Purpose of the Study:
- To identify prognostic factors associated with anti-neuronal antibody (ANA) seropositivity in a Turkish cohort.
- To analyze the relationship between antibody type, clinical presentation, and patient outcomes.
Main Methods:
- A cohort of 27 ANA-seropositive patients was analyzed.
- ANA detection utilized immunofluorescence, immunoblot, and cell-based assays.
- Clinical data, tumor status, MRI, and oligoclonal bands (OCB) were correlated with prognosis and treatment response.
Main Results:
- N-methyl-D-aspartate receptor (NMDAR), Hu, and Ma2 antibodies were most prevalent.
- Antibodies targeting extracellular or synaptic antigens correlated with good prognosis and treatment response.
- Tumor presence, cranial MRI lesions, or OCB were not significant prognostic indicators.
Conclusions:
- Antibody type is the most significant prognostic factor in ANA-seropositive patients.
- NMDAR, Hu, and Ma2 antibodies represent the most common ANA targets in this cohort.
- Prognosis is primarily determined by the specific antibody identified.
Related Concept Videos
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Transcription Factors
Position-effect Variegation
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Position and Displacement
Serial Position Effect

